This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Keren-Or Amar: Innovator in Biopharmaceuticals
Introduction
Keren-Or Amar is a notable inventor based in Kiryat Bialik, Israel. He has made significant contributions to the field of biopharmaceuticals, particularly through his work on isolated polypeptides of CD44. His innovative research has led to the development of new therapeutic options for inflammatory diseases.
Latest Patents
Keren-Or Amar holds 2 patents related to isolated polypeptides of CD44. His latest patents focus on providing isolated polypeptides consisting of specific amino acid sequences. These polypeptides exhibit anti-inflammatory activity and are designed for use in pharmaceutical compositions aimed at treating inflammatory diseases. The patents detail the compositions of matter, fusion proteins, and their applications in medical treatments.
Career Highlights
Keren-Or Amar is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at Yissum has allowed him to collaborate with leading researchers and contribute to advancements in the biopharmaceutical sector. His innovative approach and dedication to research have positioned him as a key figure in his field.
Collaborations
Keren-Or has worked alongside talented colleagues, including David Naor and Lora Eshkar-Sebban. Their collaborative efforts have further enhanced the research and development of new therapeutic solutions.
Conclusion
Keren-Or Amar's contributions to the field of biopharmaceuticals through his patents and research collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of inflammatory diseases.